The global pulmonary drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to fuel the market growth include a rise in the prevalence of chronic diseases such as bronchitis, tuberculosis, and chronic obstructive pulmonary disease and a rise in tobacco smoking. Pulmonary drug […]
